CD4 and neoplasm: It was recently reported that patients with splenic volume increase have greater numbers of spleen CD4 regulatory T cells and programmed death ligand 1-and ligand 2-expressing cells than those without splenic volume increase, suggesting that patients with splenic volume increase have poorer tumor immunity than those without it [25].